Population
Patients with supraventricular and ventricular arrhythmias, or at high risk for arrhythmic events and sudden…
Design
Guideline
Authors
Loading...
Amiodarone may improve outcomes in high-risk arrhythmia patients; leaves open its optimal place among therapies pending further RCTs.
Provides practical guidelines for the clinical use of amiodarone in the management of supraventricular and ventricular arrhythmias.
Nora Goldschlager (2000) studied this question. Amiodarone is an important treatment for supraventricular and ventricular arrhythmias, with an emerging role in improving outcomes for patients at high risk for arrhythmic events and sudden death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: